A clinical trial to study the effects of Doctors advice to stop smoking in TB and HIV patients

Completed

• Conditions: Nicotine dependence, (2) ICD-10 Condition: A150||Tuberculosis of lung, (3) ICD-10 Condition: B20||Human immunodeficiency virus [HIV]disease,

• Registration Number: CTRI/2009/091/000962
• Lead Sponsor: Tuberculosis Research Centre

Brief Summary

Smoking is one of the major public health problems globally. Smokers who are also infected HIV develop additional risks, in addition to the general health consequences of smoking and also morbidity and mortality is higher in pulmonary tuberculosis patients with smoking.The study is a randomized clinical trial to determine the efficacy of Physician's advise strategy in quitting smoking in patients with HIV and patients with TB and to compare its efficacy rate with that of counselor counseling and administering a brochure with study materials. The primary outcome measure will be smoking cessation rate at 1 month after intervention.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-03-15
• Study Completion: 2012-03-29
• Last Update Posted: 2018-10-29

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

• HIV group: Inclusion criteria 1. HIV positive (ELISA / Rapid test.
• Reactive) 2. May or may not have TB. 3. Eighteen years or older 4. Willing to give informed consent 5. Current Smoker 6. Willing to undergo carbon monoxide monitor test TB group: Inclusion criteria 1. Newly detected pulmonary tuberculosis (Sputum AFB.
• positive) 2. Eighteen years or older 3. Willing to give informed consent 4. Current Smokers 5. Willing to undergo carbon monoxide monitor test.

Exclusion Criteria

• Exclusion criteria(both HIV and TB group)1.
• People who do not understand Tamil language.2. People who have idea of relocating to another geographic area within the study period3.
• Severely ill / moribund status.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Smoking Cessation	1 month after intervention

Trial Locations

Locations (1)

Madurai, Subcentre of Tuberculosis Research Centre; 🇮🇳 Madurai, TAMIL NADU, India

Madurai, Subcentre of Tuberculosis Research Centre

🇮🇳Madurai, TAMIL NADU, India

Dr.S.Ramesh Kumar

Principal investigator

04522534351

drrameshskumar@yahoo.co.in